American Healthcare REIT (AHR) slips as rising long-term yields and dilution concerns weigh on REIT sentiment

American Healthcare REIT (AHR) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop looks driven by a risk-off tape for rate-sensitive REITs as long-term Treasury yields pushed to multi-year highs, which can pressure income-oriented equities and REIT valuations. Investors may also be re-focusing on potential equity dilution from the company’s large at-the-market (ATM) program and forward-sale activity disclosed alongside recent results.

Details:

Long-dated U.S. Treasury yields rose sharply this week, a backdrop that often weighs on REITs as their dividends compete with higher bond yields and their financing costs can rise.

The company disclosed outstanding unsettled forward sale agreements tied to its ATM program, implying a meaningful amount of potential future share issuance if physically settled.

The company’s recent quarterly update included discussion of equity issuance activity and the ATM/forward-sale mechanics, which can create near-term supply/dilution overhang even when fundamentals are improving.

This could also be simple profit-taking after the stock’s recent post-earnings move, as investors reassess the pace and timing of capital raising.

Sources:

U.S. SEC, American Healthcare REIT (Investor Relations), ABC Columbia

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AHR Insider Trading Activity

$AHR insiders have traded $AHR stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $AHR stock by insiders over the last 6 months:

JEFFREY T HANSON has made 0 purchases and 2 sales selling 54,778 shares for an estimated $2,650,399.
MARK E. FOSTER (EVP, GC & Secretary) sold 2,000 shares for an estimated $97,100

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$AHR Hedge Fund Activity

We have seen 283 institutional investors add shares of $AHR stock to their portfolio, and 248 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 8,604,835 shares (+42.7%) to their portfolio in Q1 2026, for an estimated $405,804,018
ROYAL BANK OF CANADA removed 5,877,096 shares (-95.4%) from their portfolio in Q1 2026, for an estimated $277,163,847
STATE STREET CORP added 2,459,374 shares (+34.7%) to their portfolio in Q1 2026, for an estimated $115,984,077
CANADA PENSION PLAN INVESTMENT BOARD added 2,251,400 shares (+inf%) to their portfolio in Q1 2026, for an estimated $106,176,023
QUBE RESEARCH & TECHNOLOGIES LTD removed 2,150,601 shares (-90.5%) from their portfolio in Q1 2026, for an estimated $101,422,343
TD ASSET MANAGEMENT INC added 2,002,053 shares (+inf%) to their portfolio in Q1 2026, for an estimated $94,416,819
NORGES BANK added 1,870,143 shares (+271.7%) to their portfolio in Q4 2025, for an estimated $88,008,929

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AHR Analyst Ratings

Wall Street analysts have issued reports on $AHR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Truist Securities issued a "Buy" rating on 01/20/2026

To track analyst ratings and price targets for $AHR, check out Quiver Quantitative's $AHR forecast page.

$AHR Price Targets

Multiple analysts have issued price targets for $AHR recently. We have seen 5 analysts offer price targets for $AHR in the last 6 months, with a median target of $57.0.

Here are some recent targets:

Michael Lewis from Truist Securities set a target price of $57.0 on 03/13/2026
Nicholas Yulico from Scotiabank set a target price of $59.0 on 03/11/2026
Nick Joseph from Citigroup set a target price of $55.0 on 03/02/2026
Aaron Hecht from Citizens set a target price of $60.0 on 02/05/2026
Juan Sanabria from BMO Capital set a target price of $55.0 on 01/29/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.